CLINICAL_TRIALS trial_result · 2018-09-10

Clinical Trial Update: Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer [Phase 2]

Phase 2 trial update of TH-302 monotherapy as second-line treatment in advanced biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Seoul National University Hospital | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED